S023 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
DESCRIPTION
This session is a case-based discussion of complex dermatologic problems that have systemic implications. We will utilize an Audience Response System for this session and therefore, Handouts WILL NOT be provided prior to the session. Speakers will be asked to upload a handout after the session. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Diagnose skin diseases that are associated with internal manifestations more effectively.
Develop an appropriate, yet cost effective, method of evaluation for patient with complex medical/dermatological disease.
Formulate an evidence-based management plan for patients with complex medical/dermatological disease.
SCHEDULE
1:00 PM
Introduction, Case 1
Courtney Reynolds Schadt, MD, FAAD
1:20 PM
Case 2
Anna Kristine Dewan, MHS, MD, FAAD
1:35 PM
Case 3
John D Strickley, MD, FAAD
1:50 PM
Case 4
Jeffrey Phillip Callen, MD, FAAD
2:05 PM
Q&A
Courtney Reynolds Schadt, MD, FAAD, Jeffrey Phillip Callen, MD, FAAD, Anna Kristine Dewan, MHS, MD, FAAD, John D Strickley, MD, FAAD
2:10 PM
Case 5
Kanade Shinkai, MD, PhD, FAAD
2:25 PM
Case 6
Cindy Owen, MD, FAAD
2:40 PM
Case 7
Nicole Fett, MD, FAAD
2:55 PM
Q&A
Nicole Fett, MD, FAAD, Cindy Owen, MD, FAAD, Kanade Shinkai, MD, PhD, FAAD
3:00 PM
Case 8
Andrea Maderal, MD, FAAD
3:15 PM
Case 9
Jean L Bolognia, MD, FAAD
3:30 PM
Case 10
Patricia Suzanne Todd, MD, FAAD
3:45 PM
Q&A
DIRECTOR
Courtney Reynolds Schadt, MD, FAAD
SPEAKERS
Jean L Bolognia, MD, FAAD
Jeffrey Phillip Callen, MD, FAAD
Anna Kristine Dewan, MHS, MD, FAAD
Nicole Fett, MD, FAAD
Andrea Maderal, MD, FAAD
Cindy Owen, MD, FAAD
Kanade Shinkai, MD, PhD, FAAD
John D Strickley, MD, FAAD
Patricia Suzanne Todd, MD, FAAD
HANDOUTS
DISCLOSURES
Jean L Bolognia, MD, FAAD
Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Anna Kristine Dewan, MHS, MD, FAAD
No financial relationships exist with ineligible companies.
Nicole Fett, MD, FAAD
Astra Zeneca – Investigator(Fees); UpToDate – Other(Honoraria);
Andrea Maderal, MD, FAAD
argenx – Consultant (1099 relationship)(Fees); Biogen – Investigator(Other Financial Benefit); Johnson and Johnson – Advisory Board(Fees); Medicines Development for Global Health – Data Safety Monitoring Board(Honoraria);
Cindy Owen, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bluefin – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Veradermics – Investigator(Grants/Research Funding); Zura Bio – Investigator(Grants/Research Funding);
Courtney Reynolds Schadt, MD, FAAD
No financial relationships exist with ineligible companies.
Kanade Shinkai, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
John D Strickley, MD, FAAD
No financial relationships exist with ineligible companies.
Patricia Suzanne Todd, MD, FAAD
No financial relationships exist with ineligible companies.